GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a ...
GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, ...
The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...
Seeking Alpha on MSN5h
GSK, Sanofi, CSL said to win $72M U.S. bird flu vaccine contract (update)Sanofi (SNY), and CSL (CSLLY) win $72M U.S. contract to expand bird flu vaccine production amid fears of human transmission.
CSL Seqirus, a business of CSL (ASX: CSL), has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response ...
The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to ...
CSL shares have been heavily sold and now rest near their three-month lows. Is now the time to buy? Let's see what the ...
The 2018-2019 influenza season is one such case. The vaccine’s effectiveness during that year was an abysmal 29%, according ...
At the current CSL share price, this ASX 200 healthcare giant is trading on a dividend yield of 0.97%. Motley Fool investing ...
Brad Clibborn at BAEP says Fisher & Paykel Healthcare surprised the most in reporting season, and outlines why he is bullish ...
CSL Group, a leader in ritical IoT Connectivity solutions, is pleased to announce the appointment of Glenn Fishwick as Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback